TKT and hepatocellular carcinoma: The same group has successfully used transcriptional targeting by AAV vector-mediated HSV/TK gene transfer under the control of an alpha-fetoprotein enhancer and albumin promoter to specifically target AFP-positive human hepatocellular carcinoma cells in a nude mouse model [93].